Clean Power Hydrogen suspends testing and share trading following electrolyser incident (CPH2)

Clean Power Hydrogen PLC (LSE:CPH2) has halted testing activities and requested a suspension of trading in its AIM-listed shares after a serious incident occurred during the final factory acceptance test of its 1MW MFE220 membrane-free electrolyser system.

The event took place during the third and concluding stage of the testing programme and resulted in an automatic shutdown of the unit. The incident caused significant damage to equipment, prompting the company to suspend operations while a detailed investigation is carried out to determine the cause and assess the implications for the technology and development timetable.

As a result of the setback, completion of the factory acceptance testing process has been materially delayed. The company said the incident has also affected ongoing discussions with potential investors regarding an equity fundraising, placing additional pressure on working capital resources as management evaluates available financing options.

Clean Power Hydrogen is reviewing its insurance coverage and contractual arrangements with customers as part of its response to the incident. The board said it is also assessing a range of strategic alternatives and funding solutions aimed at stabilising the business and supporting future development activities while the investigation is underway.

The company’s outlook remains challenging, reflecting its limited revenue base, continuing losses and significant cash consumption. The incident adds further uncertainty to near-term funding requirements and commercial progress. While technical indicators had previously shown positive momentum in the share price, valuation remains difficult to assess given the company’s loss-making position and lack of dividend payments.

More about Clean Power Hydrogen PLC

Clean Power Hydrogen PLC is a UK-based hydrogen technology company focused on developing membrane-free electrolyser systems capable of producing high-purity hydrogen and oxygen. The company’s technology is designed to reduce the lifetime cost of hydrogen production while supporting decentralised energy applications.

Listed on AIM under the ticker CPH2, the group targets a range of markets including wastewater treatment, renewable energy integration, data centre backup power, medical and life sciences applications, and heavy-duty transport. Through its patented technology platform and ongoing research and development efforts, the company aims to establish a competitive position within the emerging hydrogen economy.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *